Led by the pharmaceutical manufacturing industry, IP-intensive manufacturing industries contribute extraordinary economic value to the U.S. economy. Compared to other IP-intensive and non-IP intensive manufacturing industries, the pharmaceutical manufacturing industry had the highest R&D...

Appraising pharmaceutical products at different time points of their lifecycle open ups the possibility of reversals in estimates of economic value. A product that erstwhile was rated “not cost-effective” could later on become 'cost-effective'. This paper investigates, within a single...

Title Page -- Copyright Page -- Contents -- List of Contributors -- Preface -- Chapter 1 Introduction -- 1.1 Quality by Design Overview -- 1.2 Pharmaceutical Industry -- 1.3 Quality by Design Details -- 1.4 Chapter Summaries -- References -- Chapter 2 An Overview of the Role of Mathematical...

Our study puts special attention to the fact that R&D cooperations in the pharmaceutical industry are formed at different stages throughout the drug development process. We study if the timing to engage in R&D cooperations in the pharmaceutical industry has different impacts on the technology...

Patent-based measures are frequently used as indicators in empirical research on innovation and technology as well as on firms' strategies and organizational choices to characterize inventions or, more generally, innovative activities and the technological capabilities of organizations. A clear...

Patent-based measures are frequently used as indicators in empirical research on innovation and technological change. Currently, there is little evidence as to what extent patent-based indicators relate to product market outcomes. Using a unique dataset that links outcomes from product...